TrueBinding Highlights the Potential of TB006’s Unique Mechanism of Action as a Novel Approach for the Treatment of Alzheimer’s Disease at the 15th Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Biz Wire Express,
GlobeNewswire 2022-12-06 Novel antibody, TB006, demonstrated improvements in cognition and function and was well tolerated in a…